The first six months of 2014 have seen as many pharmaceutical initial public offerings as the whole of 2013. A total of 52 IPOs have been completed in 2014, whereas 2013 saw a total of 54 IPOs. The industry is experiencing heightened investment activity now that the...
Boston Pharmaceutical Recruiters
Controlling Cholesterol through R&D
Drug developers are spending billions on R&D and extensive studies on treatments for high cholesterol based on genomic sequencing. According to Damian Garde of Fiercebiotech, Amgen is the current leader and may be the first to launch a new drug; the company is...
Top Pharma Companies on Social Media – And What You Can Learn From Them!
According to Tracy Stanton of Fiercepharmamarketing, pharmaceutical companies have so far shown caution with respect to the use of social media. Engagement with health care professionals and the US Food and Drug Administration (USFDA) is often in response to...